BeyondSpring competitorsClear all

BeyondSpring's top competitors include TESARO, Omeros, Athersys and Otonomy.
BeyondSpring
BeyondSpring
BeyondSpring is a clinical-stage biopharmaceutical company.
TESARO
TESARO
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
Omeros
Omeros
Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Founding Date
Founding Date
2010
Founding Date
2010
Founding Date
1994
Founding Date
1995
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Locations
Waltham, US HQ
Wien, AT
Boulogne Billancourt, FR
München, DE
Roma, IT
Madrid, ES
Zug, CH
see more
Locations
Seattle, US HQ
Locations
Cleveland, US HQ
Canton, US
Locations
San Diego, US HQ
Employees
Employees
5237% increase
Employees
446
Employees
173
Employees
7514% increase
Employees
498% decrease
Valuation ($)
Valuation ($)
499.6 m
Valuation ($)
4.1 b
Valuation ($)
730.1 m
Valuation ($)
199 m
Valuation ($)
109.8 m
Twitter followers
Twitter followers
52
Twitter followers
2.3 k
Twitter followers
158
Twitter followers
1.2 k
Twitter followers
231
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
12
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
13.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
406250
Alexa Website Rank
559054
Alexa Website Rank
511963
Alexa Website Rank
609659
Alexa Website Rank
318925

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$223.3m (FY, 2017)
Revenue (est.)
$29.9m (FY, 2018)
Revenue (est.)
$24.3m (FY, 2018)
Revenue (est.)
$745k (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
$41.1m (FY, 2017)
Cost of goods
$512k (FY, 2018)
Cost of goods
N/A
Cost of goods
$946k (FY, 2018)
Gross profit
Gross profit
N/A
Gross profit
$182.2m (FY, 2017)
Gross profit
$29.4m (FY, 2018)
Gross profit
N/A
Gross profit
($201k) (FY, 2018)
Net income
Net income
($57.5m) (FY, 2018)
Net income
($496.1m) (FY, 2017)
Net income
($126.8m) (FY, 2018)
Net income
($24.3m) (FY, 2018)
Net income
($50.4m) (FY, 2018)

Operating

Patent Applications
Patent Applications
56 (FY, 2018)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
170 (FY, 2016)
Patent Applications
N/A
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
492 (FY, 2016)
Patents (US)
21 (FY, 2016)
Patents (US)
N/A
Patents Issued
Patents Issued
20 (FY, 2018)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Patents Issued
88 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
2 (FY, 2018)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
3 (FY, 2018)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
2 (FY, 2016)
Preclinical Phase Products
Preclinical Phase Products
5 (FY, 2018)
Preclinical Phase Products
N/A
Preclinical Phase Products
N/A
Preclinical Phase Products
N/A
Preclinical Phase Products
1 (FY, 2016)
Products
Products
N/A
Products
2 (FY, 2016)
Products
N/A
Products
N/A
Products
1 (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 3.8m
Total funding raised
$ 161m
Total funding raised
$ 354.8m
Total funding raised
$ 9m
Total funding raised
$ 153.4m
For sources of this data, please see the company profile

View company profiles

TESARO
HQ
Waltham, US
Employees
446

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

View company
Omeros
HQ
Seattle, US
Employees
173

Omeros Corporation is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

View company
Athersys
HQ
Cleveland, US
Employees
75↑ 14% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company
Otonomy
HQ
San Diego, US
Employees
49↓ 8% decrease

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company